vs
Apellis Pharmaceuticals, Inc.（APLS）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是Apellis Pharmaceuticals, Inc.的1.1倍（$225.0M vs $199.9M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs -5.9%），GIBRALTAR INDUSTRIES, INC.自由现金流更多（$26.2M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -12.3%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
APLS vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.1倍
$199.9M
营收增速更快
ROCK
高出30.9%
-5.9%
自由现金流更多
ROCK
多$40.5M
$-14.3M
两年增速更快
APLS
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $225.0M |
| 净利润 | $-59.0M | — |
| 毛利率 | — | 25.3% |
| 营业利润率 | -25.6% | 7.9% |
| 净利率 | -29.5% | — |
| 营收同比 | -5.9% | 24.9% |
| 净利润同比 | -62.2% | — |
| 每股收益（稀释后） | $-0.40 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSROCK
| Q4 25 | $199.9M | $225.0M | ||
| Q3 25 | $458.6M | $310.9M | ||
| Q2 25 | $178.5M | $309.5M | ||
| Q1 25 | $166.8M | $290.0M | ||
| Q4 24 | $212.5M | $180.1M | ||
| Q3 24 | $196.8M | $277.1M | ||
| Q2 24 | $199.7M | $273.6M | ||
| Q1 24 | $172.3M | $292.5M |
净利润APLSROCK
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $215.7M | $-89.1M | ||
| Q2 25 | $-42.2M | $26.0M | ||
| Q1 25 | $-92.2M | $21.1M | ||
| Q4 24 | $-36.4M | — | ||
| Q3 24 | $-57.4M | $34.0M | ||
| Q2 24 | $-37.7M | $32.2M | ||
| Q1 24 | $-66.4M | $24.9M |
毛利率APLSROCK
| Q4 25 | — | 25.3% | ||
| Q3 25 | — | 26.6% | ||
| Q2 25 | — | 28.4% | ||
| Q1 25 | — | 26.8% | ||
| Q4 24 | — | 29.0% | ||
| Q3 24 | — | 29.4% | ||
| Q2 24 | — | 30.5% | ||
| Q1 24 | — | 28.9% |
营业利润率APLSROCK
| Q4 25 | -25.6% | 7.9% | ||
| Q3 25 | 48.7% | 12.8% | ||
| Q2 25 | -18.6% | 12.8% | ||
| Q1 25 | -50.0% | 8.8% | ||
| Q4 24 | -12.3% | 13.3% | ||
| Q3 24 | -24.0% | 15.6% | ||
| Q2 24 | -14.7% | 14.9% | ||
| Q1 24 | -36.0% | 10.8% |
净利率APLSROCK
| Q4 25 | -29.5% | — | ||
| Q3 25 | 47.0% | -28.6% | ||
| Q2 25 | -23.6% | 8.4% | ||
| Q1 25 | -55.3% | 7.3% | ||
| Q4 24 | -17.1% | — | ||
| Q3 24 | -29.2% | 12.3% | ||
| Q2 24 | -18.9% | 11.8% | ||
| Q1 24 | -38.5% | 8.5% |
每股收益（稀释后）APLSROCK
| Q4 25 | $-0.40 | — | ||
| Q3 25 | $1.67 | $-2.98 | ||
| Q2 25 | $-0.33 | $0.87 | ||
| Q1 25 | $-0.74 | — | ||
| Q4 24 | $-0.30 | — | ||
| Q3 24 | $-0.46 | $1.11 | ||
| Q2 24 | $-0.30 | $1.05 | ||
| Q1 24 | $-0.54 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $115.7M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $370.1M | $950.4M |
| 总资产 | $1.1B | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资APLSROCK
| Q4 25 | $466.2M | $115.7M | ||
| Q3 25 | $479.2M | $89.4M | ||
| Q2 25 | $370.0M | $43.3M | ||
| Q1 25 | $358.4M | $25.1M | ||
| Q4 24 | $411.3M | $269.5M | ||
| Q3 24 | $396.9M | $228.9M | ||
| Q2 24 | $360.1M | $179.1M | ||
| Q1 24 | $325.9M | $146.7M |
总债务APLSROCK
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | $93.1M | $0 |
股东权益APLSROCK
| Q4 25 | $370.1M | $950.4M | ||
| Q3 25 | $401.2M | $951.8M | ||
| Q2 25 | $156.3M | $1.0B | ||
| Q1 25 | $164.2M | $1.0B | ||
| Q4 24 | $228.5M | $1.0B | ||
| Q3 24 | $237.1M | $1.0B | ||
| Q2 24 | $264.3M | $975.7M | ||
| Q1 24 | $266.7M | $940.2M |
总资产APLSROCK
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $821.4M | $1.5B | ||
| Q1 25 | $807.3M | $1.4B | ||
| Q4 24 | $885.1M | $1.4B | ||
| Q3 24 | $901.9M | $1.4B | ||
| Q2 24 | $904.5M | $1.4B | ||
| Q1 24 | $831.9M | $1.3B |
负债/权益比APLSROCK
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | 0.35× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $26.2M |
| 自由现金流率自由现金流/营收 | -7.1% | 11.7% |
| 资本支出强度资本支出/营收 | 0.1% | 4.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $120.6M |
8季度趋势，按日历期对齐
经营现金流APLSROCK
| Q4 25 | $-14.2M | $35.5M | ||
| Q3 25 | $108.5M | $73.0M | ||
| Q2 25 | $4.4M | $44.9M | ||
| Q1 25 | $-53.4M | $13.7M | ||
| Q4 24 | $19.4M | $19.9M | ||
| Q3 24 | $34.1M | $64.7M | ||
| Q2 24 | $-8.3M | $36.5M | ||
| Q1 24 | $-133.0M | $53.2M |
自由现金流APLSROCK
| Q4 25 | $-14.3M | $26.2M | ||
| Q3 25 | $108.3M | $64.8M | ||
| Q2 25 | $4.4M | $27.3M | ||
| Q1 25 | $-53.4M | $2.3M | ||
| Q4 24 | $19.3M | $14.1M | ||
| Q3 24 | — | $60.5M | ||
| Q2 24 | $-8.4M | $33.5M | ||
| Q1 24 | $-133.3M | $48.8M |
自由现金流率APLSROCK
| Q4 25 | -7.1% | 11.7% | ||
| Q3 25 | 23.6% | 20.8% | ||
| Q2 25 | 2.5% | 8.8% | ||
| Q1 25 | -32.0% | 0.8% | ||
| Q4 24 | 9.1% | 7.8% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | -4.2% | 12.2% | ||
| Q1 24 | -77.3% | 16.7% |
资本支出强度APLSROCK
| Q4 25 | 0.1% | 4.1% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.0% | 5.7% | ||
| Q1 25 | 0.0% | 3.9% | ||
| Q4 24 | 0.0% | 3.3% | ||
| Q3 24 | 0.0% | 1.5% | ||
| Q2 24 | 0.0% | 1.1% | ||
| Q1 24 | 0.2% | 1.5% |
现金转化率APLSROCK
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | 1.73× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
